Pediatrix Medical Group, Inc. (MD) Q1 2025 Earnings Call

Investor webinar replay

Replay transcript excerpt

Certain statements and information during this conference call may be deemed to be forward-looking statements within the meaning of the Federal Private Securities Mitigation Reform Act of 1995. These forward-looking statements are based on assumptions and assessments made by pediatrics management in light of their experience and assessment of historical trends, current conditions, expected future developments, and other factors they believe to be appropriate. Any forward-looking statements made during this call are made as of today, and pediatrics undertakes no duty to update or revise any such statements, whether as a result of new information, future events, or otherwise. Important factors that could cause actual results, developments, and business decisions to differ materially from forward-looking statements are described in the company's filing with the SEC, including the sections entitled Risk Factors. In these remarks by management, we will be discussing non-GAAP financial metrics. A reconciliation of these non-GAAP financial measures to the most comparable GAAP measures can be found in the morning's earnings press release, our quarterly and annual reports, and on our website at www.pediatrics.com. With that, I will turn the call over to Mark or Dan. Pediatrics Medical Group's Chief Executive Officer. Thank you, Operator. Good morning, everyone. With me today is Cassandra Rossi, our Chief Financial Officer. Our first quarter results exceeded our expectations, driven by same-unit revenue growth of over 6%. This included strong volumes in our hospital-based services, with NICU days increasing by 2%, as well as more modest growth in maternal-fetal medicine, along with continued favorable payer metrics. Our practice-level operating expenses continue to reflect the...